Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroectodermal Tumors, Primitive, Peripheral × Radiotherapy, Intensity-Modulated × 90 days × Clear all

Sponsor

Conditions

Squamous Cell Carcinoma of Head and Neck 17 Oropharyngeal Neoplasms 11 Mouth Neoplasms 7 Laryngeal Neoplasms 7 Nasopharyngeal Carcinoma 6 Hypopharyngeal Neoplasms 6 Carcinoma 6 Prostatic Neoplasms 5 Carcinoma, Squamous Cell 5 Glioblastoma 4 Uterine Cervical Neoplasms 3 Rectal Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Papillomavirus Infections 3 Leukemia, Myeloid, Acute 3 Head and Neck Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Neoplasm Metastasis 2 Nasopharyngeal Neoplasms 2 Myelodysplastic Syndromes 2 Lymphatic Metastasis 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Breast Neoplasms 2 Anus Neoplasms 2 Virus Diseases 1 Vaginal Neoplasms 1 Tumor Virus Infections 1 Thyroid Carcinoma, Anaplastic 1 Stomatitis 1

Interventions

X-Rays 3 Specimen Handling 3 Phantoms, Imaging 3 Nuclear Medicine Department, Hospital 3 Magnetic Resonance Spectroscopy 3 Biopsy 3 ivosidenib 2 erdafitinib 2 ensartinib 2 Temozolomide 2 ulixertinib 1 tipifarnib 1 temsirolimus 1 tazemetostat 1 talazoparib 1 selpercatinib 1 palbociclib 1 olaparib 1 larotrectinib 1 irinotecan sucrosofate 1 Vincristine 1 Vemurafenib 1 Surgical Procedures, Operative 1 Sorafenib 1 Radiation 1 Proton Therapy 1 Liquid Biopsy 1 LY3023414 1 Ifosfamide 1 Etoposide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡